Ebola vaccine developed in Italy has 10-month effectiveness

First phase of human testing already announced

(ANSA) - Rome, September 8 - A vaccine against the Ebola virus developed in Italy has proven to be effective for up to ten months in monkeys, science journal Nature reported. The vaccine was developed by a team of American and Italian researchers at the IBRM Science Park in Pomezia, just south of Rome.

The first phase of human testing of the vaccine has already been announced, and the vaccine is one of two that the World Health Organization is relying on to help fight the current deadly outbreak in West Africa.